Skip to content

CVRx, Inc. CVRX Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B0.0%
Boston Scientific logo
Boston ScientificBSX
1.5B+0.1%
Medtronic logo
MedtronicMDT
1.3B-0.1%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
33.7M+7.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
40.5M+3.2%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
28.7M-5.3%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s shares (diluted)?
CVRx, Inc. (CVRX) reported shares (diluted) of 26.4M in Q1 2026.
How has CVRx, Inc.'s shares (diluted) changed year-over-year?
CVRx, Inc.'s shares (diluted) increased by 1.9% year-over-year, from 25.9M to 26.4M.
What is the long-term trend for CVRx, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), CVRx, Inc.'s shares (diluted) has grown at a 35.2% compound annual growth rate (CAGR), from 31.2M to 104.2M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.